Literature DB >> 9149058

Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies.

P Sikirić1, D Mikus, S Seiwerth, Z Grabarević, R Rucman, M Petek, V Jagić, B Turković, I Rotkvić, S Mise, I Zoricić, J Perić, P Konjevoda, D Perović, L Jurina, M Hanzevacki, J Separović, M Gjurasin, S Jadrijević, N Jelovac, P Miklić, G Buljat, A Marović.   

Abstract

A superior effectiveness in various lesion assays was noted for the novel pentadecapeptide BPC 157, originated from human gastric juice protein (BPC) and claimed to be a cytoprotective agent. From this viewpoint, as a previously untreated experimental improvement to create an acid-free environmental for cytoprotection studies, total gastrectomy was done 24 hr before the ulcerogenic procedure. In the absence of stomach and gastric acid, the damaging effects of cysteamine (400 mg/kg subcutaneously, death 24 hr thereafter), to date thought to be an acid-related duodenal ulcerogen, and the BPC 157 cytoprotective effect (10 microg or 10 ng/kg intraperitoneally) were further challenged. BPC 157 was compared with reference agents [cimetidine (50), ranitidine (10), omeprazole (10), bromocriptine (10) and atropine (10) (mg/kg intraperitoneally, 1 hr before cysteamine] known to be also cytoprotective. In naive rats, with intact stomach, all of them showed a strong beneficial effect. Interestingly, in gastrectomized animals, the application of BPC 157 or the reference agents before cysteamine significantly prevented the otherwise severe duodenal lesion development noted in the control gastrectomized cysteamine rats. In groups without cysteamine, no lesions were noted (laparotomy, gastrectomy only, 24 or 48 hr postsurgical period), nor was lesion potentiation seen in cysteamine-treated laparotomized animals. In summary, these findings--equal damaging effect of cysteamine and equal protection of pentadecapeptide BPC 157 and reference agents in gastrectomized and rats with intact stomach--seem to be particularly relevant for a cytoprotective viewpoint. Without a stomach, the cysteamine damaging effect was convincingly defined as an essential gastric acid-independent injury (analogous to ethanol gastric lesions). Likewise, a high "cytoprotective capacity," apparently acid independent, common for all tested agents (novel pentadecapeptide BPC 157, cimetidine, ranitidine, omeprazole and atropine) could be clearly stressed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149058     DOI: 10.1023/a:1018893220943

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  The pharmacological properties of the novel peptide BPC 157 (PL-10).

Authors:  P Sikiric
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

2.  Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress.

Authors:  P Sikirić; B Mazul; S Seiwerth; Z Grabarević; R Rucman; M Petek; V Jagić; B Turković; I Rotkvić; S Mise; I Zoricić; L Jurina; P Konjevoda; M Hanzevacki; M Gjurasin; J Separović; D Ljubanović; B Artuković; M Bratulić; M Tisljar; P Miklić; J Sumajstorcić
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

3.  Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.

Authors:  G Sener-Muratoğlu; K Paskaloğlu; S Arbak; C Hürdağ; G Ayanoğlu-Dülger
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

4.  Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats.

Authors:  Marko Sever; Robert Klicek; Bozo Radic; Luka Brcic; Ivan Zoricic; Domagoj Drmic; Mihovil Ivica; Ivan Barisic; Spomenko Ilic; Lidija Berkopic; Alenka Boban Blagaic; Marijana Coric; Danijela Kolenc; Hrvoje Vrcic; Tomislav Anic; Sven Seiwerth; Predrag Sikiric
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

5.  Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole.

Authors:  Sandra Skorjanec; Zdravko Dolovski; Ivan Kocman; Luka Brcic; Alenka Blagaic Boban; Lovorka Batelja; Marjana Coric; Marko Sever; Robert Klicek; Lidija Berkopic; Bozo Radic; Domagoj Drmic; Danijela Kolenc; Spomenko Ilic; Vedran Cesarec; Ante Tonkic; Ivan Zoricic; Stjepan Mise; Mario Staresinic; Mihovil Ivica; Martina Lovric Bencic; Tomislav Anic; Sven Seiwerth; Predrag Sikiric
Journal:  Dig Dis Sci       Date:  2008-07-23       Impact factor: 3.199

Review 6.  Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

Authors:  Sven Seiwerth; Marija Milavic; Jaksa Vukojevic; Slaven Gojkovic; Ivan Krezic; Lovorka Batelja Vuletic; Katarina Horvat Pavlov; Andrea Petrovic; Suncana Sikiric; Hrvoje Vranes; Andreja Prtoric; Helena Zizek; Tajana Durasin; Ivan Dobric; Mario Staresinic; Sanja Strbe; Mario Knezevic; Marija Sola; Antonio Kokot; Marko Sever; Eva Lovric; Anita Skrtic; Alenka Boban Blagaic; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

7.  Antioxidant effects of some drugs on ethanol-induced ulcers.

Authors:  Mira Popovic; Snezana Janicijevic-Hudomal; Biljana Kaurinovic; Julijana Rasic; Svetlana Trivic
Journal:  Molecules       Date:  2009-02-18       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.